Zealand Pharma A/S
ZLDPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $49,569 | $9,088,284 | $8,092 | $9,056 |
| % Growth | -99.5% | 112,212% | -10.6% | – |
| Cost of Goods Sold | $1,133 | $410 | $405 | $408 |
| Gross Profit | $6,640 | $9,087,874 | $7,687 | $8,648 |
| % Margin | 13.4% | 100% | 95% | 95.5% |
| R&D Expenses | $50,182 | $464,145 | $290,321 | $253,917 |
| G&A Expenses | $159,147 | $69,242 | $65,467 | -$39,285 |
| SG&A Expenses | $28,793 | $110,460 | $102,828 | -$20,812 |
| Sales & Mktg Exp. | $31,706 | $41,218 | $37,361 | $18,473 |
| Other Operating Expenses | $0 | $174,846 | $21,576 | $174,820 |
| Operating Expenses | $78,975 | $749,451 | $414,725 | $407,925 |
| Operating Income | -$72,335 | $8,338,423 | -$407,038 | -$399,277 |
| % Margin | -145.9% | 91.7% | -5,030.1% | -4,409% |
| Other Income/Exp. Net | $94,588 | -$227,403 | $70,319 | $107,669 |
| Pre-Tax Income | -$366,732 | $8,111,020 | -$336,719 | -$291,608 |
| Tax Expense | $5,880 | $537,323 | -$1,376 | -$574 |
| Net Income | -$63,384 | $7,573,697 | -$335,343 | -$291,034 |
| % Margin | -127.9% | 83.3% | -4,144.1% | -3,213.7% |
| EPS | -0.9 | 107.08 | -4.75 | -4.64 |
| % Growth | -100.8% | 2,354.3% | -2.4% | – |
| EPS Diluted | -0.9 | 105.61 | -4.75 | -4.64 |
| Weighted Avg Shares Out | 70,301 | 70,729 | 70,599 | 62,688 |
| Weighted Avg Shares Out Dil | 70,301 | 71,714 | 70,599 | 62,688 |
| Supplemental Information | – | – | – | – |
| Interest Income | $108,949 | $56,361 | $41,622 | $62,609 |
| Interest Expense | $6,997 | $7,340 | $7,651 | $8,268 |
| Depreciation & Amortization | $7,223 | $6,211 | $5,959 | $6,275 |
| EBITDA | -$352,512 | $8,124,571 | -$323,109 | -$277,065 |
| % Margin | -711.2% | 89.4% | -3,992.9% | -3,059.5% |